Brinkley-Rubinstein L, et al. - Researchers here reported the 12-month outcomes of a randomized control trial in which individuals were provided Methadone maintenance treatment (MMT) while incarcerated at the Rhode Island Department of Corrections (RIDOC). Results demonstrated that 12 months post-release individuals who received continued access to MMT while incarcerated less frequently reported using heroin and engaging in injection drug use in the past 30 days. Furthermore, these individuals reported fewer non-fatal overdoses and had a higher tendency for continuously engaging in treatment in the 12-month follow-up period compared to individuals who were not receiving methadone immediately prior to release. Findings thereby suggested that providing incarcerated individuals continued access to MMT has a sustained, long-term impact on many opioid-related outcomes post-release.